Nayani Suriyarachchi
A5040228049- Leprosy Research and Treatment
- Infectious Diseases and Tuberculosis
- Tuberculosis Research and Epidemiology
- Mycobacterium research and diagnosis
- HIV/AIDS oral health manifestations
- HIV/AIDS Research and Interventions
- Syphilis Diagnosis and Treatment
Fairmed
2024
FAIRMED
2018-2021
Innovative approaches are required to further enhance leprosy control, reduce the number of people developing leprosy, and curb transmission. Early case detection, contact screening, chemoprophylaxis currently is most promising approach achieve this goal. The Leprosy Post-Exposure Prophylaxis (LPEP) programme generates evidence on feasibility integrating tracing single-dose rifampicin (SDR) administration into routine control activities in different settings. LPEP implemented within...
The Leprosy Post-Exposure Prophylaxis (LPEP) program explored the feasibility and impact of contact tracing provision single dose rifampicin (SDR) to eligible contacts newly diagnosed leprosy patients in Brazil, India, Indonesia, Myanmar, Nepal, Sri Lanka Tanzania. As programme is difficult establish short term, we apply mathematical modelling predict its long-term on incidence. individual-based model SIMCOLEP was calibrated validated historic incidence data study areas. For each area,...
Objective: Leprosy post-exposure prophylaxis with single-dose rifampicin (SDRPEP) has proven effective and feasible, is recommended by WHO since 2018. This SDR-PEP toolkit was developed through the experience of leprosy postexposure (LPEP) programme. It been designed to facilitate standardise implementation contact tracing administration in regions countries that start intervention. Results: Four tools were developed, incorporating current evidence for SDRPEP methods learnings from LPEP...